In the original version of this article that was published on April 5, 2022, the main text reports that a structure-based screen was carried out in SKMeL28 cells, but the flowchart in Figure 2A erroneously indicated that the screen was carried out in SKMeL3 cells. The figure now appears correctly online, and the authors sincerely regret the errors and any confusion they may have caused.
Figure 2A. Structure-based screening identifies RHOJ/CDC42 allosteric inhibitors with broad-spectrum anti-cancer activity (corrected)
Figure 2A. Structure-based screening identifies RHOJ/CDC42 allosteric inhibitors with broad-spectrum anti-cancer activity (original)